# Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense

> **NCT01425788** · PHASE2 · COMPLETED · sponsor: **ALK-Abelló A/S** · enrollment: 236 (actual)

## Conditions studied

- Rhino-conjunctivitis

## Interventions

- **BIOLOGICAL:** Osiris Phleum pratense
- **BIOLOGICAL:** Osiris Phleum pratense
- **BIOLOGICAL:** Osiris Phleum pratense

## Key facts

- **NCT ID:** NCT01425788
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-11
- **Final completion:** 2012-02
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2015-06-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01425788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01425788, "Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT01425788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*